Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Non-Current Assets (2020 - 2025)

BioAtla's Non-Current Assets history spans 6 years, with the latest figure at $5.8 million for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 388.66% year-over-year to $5.8 million; the TTM value through Dec 2025 reached $19.3 million, up 148.48%, while the annual FY2025 figure was $5.8 million, 388.66% up from the prior year.
  • Non-Current Assets reached $5.8 million in Q4 2025 per BCAB's latest filing, down from $6.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $7.1 million in Q4 2021 to a low of $753000.0 in Q1 2025.
  • Average Non-Current Assets over 5 years is $4.4 million, with a median of $4.4 million recorded in 2021.
  • The largest YoY upside for Non-Current Assets was 388.66% in 2025 against a maximum downside of 72.84% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $7.1 million in 2021, then dropped by 25.6% to $5.3 million in 2022, then crashed by 38.7% to $3.3 million in 2023, then crashed by 63.41% to $1.2 million in 2024, then soared by 388.66% to $5.8 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Non-Current Assets are $5.8 million (Q4 2025), $6.2 million (Q3 2025), and $6.5 million (Q2 2025).